The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: BROKER RATINGS SUMMARY: Buy Wolseley, Sell Berkeley - Goldman

Wed, 29th Jun 2016 14:39

LONDON (Alliance News) - The following shares received analyst recommendations Monday afternoon and morning:
----------
FTSE 100
----------
GOLDMAN RAISES WOLSELEY TO 'BUY' ('NEUTRAL') - TARGET 4,226 (4,294) PENCE
----------
GOLDMAN CUTS BERKELEY GROUP TO 'SELL' ('NEUTRAL') - TARGET 2,110 (4,000) PENCE
----------
GOLDMAN CUTS PERSIMMON PRICE TARGET TO 1,269 (2,280) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 365 (698) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS TAYLOR WIMPEY PRICE TARGET TO 123 (231) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS TRAVIS PERKINS PRICE TARGET TO 1,452 (2,236) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS INTU PROPERTIES PRICE TARGET TO 314 (350) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS LAND SECURITIES PRICE TARGET TO 1,200 (1,410) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS HAMMERSON PRICE TARGET TO 670 (750) PENCE - 'BUY'
----------
GOLDMAN CUTS BRITISH LAND CO PRICE TARGET TO 736 (910) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ARM HOLDINGS TO 'BUY' (CONVICTION BUY) - PRICE TARGET 1275 (1400) PENCE
----------
SHORE CAPITAL RAISES PROVIDENT FINANCIAL TO 'BUY' ('HOLD')
----------
GOLDMAN CUTS WHITBREAD PRICE TARGET TO 3,910 (4,490) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES INTERCONTINENTAL HOTELS TARGET TO 3,120 (3,090)P - 'NEUTRAL'
----------
GOLDMAN CUTS EASYJET TO 'BUY' ('CONVICTION BUY') - TARGET 1,310 (1,740) PENCE
----------
GOLDMAN RESUMES SHIRE WITH 'CONVICTION BUY LIST' - TARGET 6,300 PENCE
----------
GOLDMAN RAISES ASTRAZENECA PRICE TARGET TO 4000 (3700) PENCE - 'SELL'
----------
GOLDMAN RAISES RELX TARGET TO 1360 (1320) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES PEARSON PRICE TARGET TO 845 (800) PENCE - 'SELL'
----------
GOLDMAN CUTS INFORMA PRICE TARGET TO 836 (839) PENCE - 'CONVICTION BUY LIST'
----------
GOLDMAN CUTS ITV PRICE TARGET TO 198 (258) PENCE - 'BUY'
----------
GOLDMAN CUTS WPP PRICE TARGET TO 1,800 (1,860) PENCE - 'BUY'
----------
GOLDMAN CUTS SKY PRICE TARGET TO 1013 (1254) PENCE - 'BUY'
----------
GOLDMAN CUTS SCHRODERS PRICE TARGET TO 2,800 (3,400) PENCE - 'BUY'
----------
GOLDMAN CUTS VODAFONE PRICE TARGET TO 260 (265) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BT GROUP PRICE TARGET TO 540 (650) PENCE - 'CONVICTION BUY LIST'
----------
FTSE 250
----------
GOLDMAN CUTS COUNTRYWIDE TO 'SELL' ('NEUTRAL') - TARGET 218 (465) PENCE
----------
GOLDMAN RAISES GREAT PORTLAND TO 'NEUTRAL' ('SELL') - TARGET 690 (850) PENCE
----------
GOLDMAN RAISES DERWENT LONDON TO 'BUY' ('NEUTRAL') - TARGET 3,100 (3,815) PENCE
----------
GOLDMAN CUTS CREST NICHOLSON TO 'NEUTRAL' ('CONVICTION BUY') CUTS PRICE TARGET TO 384 (755) PENCE
----------
GOLDMAN CUTS BELLWAY TO 'NEUTRAL' ('BUY') - TARGET 1,715 (3,590) PENCE
----------
GOLDMAN CUTS REDROW TO 'NEUTRAL' ('BUY') - TARGET 301 (595) PENCE
----------
GOLDMAN CUTS MCCARTHY & STONE PRICE TARGET TO 161 (275) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS BOVIS HOMES TO 'NEUTRAL' ('BUY') - TARGET 684 (1,320) PENCE
----------
GOLDMAN RAISES SHAFTESBURY PRICE TARGET TO 1,061 (1,026) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS SEGRO PRICE TARGET TO 475 (555) PENCE - 'BUY'
----------
GOLDMAN CUTS HOWDEN JOINERY GROUP PRICE TARGET TO 376 (515) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS AA PRICE TARGET TO 340 (390) PENCE - 'BUY'
----------
GOLDMAN CUTS WILLIAM HILL PRICE TARGET TO 310 (380) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ASCENCIAL TARGET TO 269 (278) PENCE - 'BUY'
----------
GOLDMAN RAISES UBM PRICE TARGET TO 750,37 (690,70) PENCE - 'BUY'
----------
GOLDMAN CUTS TULLETT PREBON PRICE TARGET TO 315 (390) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ICAP PRICE TARGET TO 460 (520) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS MAN GROUP PRICE TARGET TO 155 (200) PENCE - 'CONVICTION BUY LIST'
----------
GOLDMAN CUTS INTERMEDIATE CAPITAL PRICE TARGET TO 565 (685) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ASHMORE GROUP PRICE TARGET TO 310 (325) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ABERDEEN ASSET MANAG PRICE TARGET TO 270 (288) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
GOLDMAN CUTS SECURE INCOME TO 'NEUTRAL' ('BUY') - TARGET 308 (355) PENCE
----------
GOLDMAN CUTS DAILY MAIL PRICE TARGET TO 584 (628) PENCE - 'SELL'
----------
GOLDMAN CUTS FOXTONS TO 'SELL' ('NEUTRAL') - TARGET 96 (198) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.